This LICENSE, MANUFACTURE AND DISTRIBUTION AGREEMENT ("Agreement") is made by
and between;

                        Desert Health Products, Inc.
                     7825 East Gelding Drive, Suite 101
                             Scottsdale Arizona
                   (602) 951-1941, Fax No. (602) 661-7163.
                        E-mail: deserthealth@att.net

a Arizona Corporation (hereinafter referred to as "DHPI"), and;

                                Royal Phoenix
                         1601 Flamingo Rd. Suite 18A
                           Las Vegas, Nevada 89118
                               (702) 866-5835
                     E-mail: first@firstimpressions.com

a   Nevada   Corporation  (hereinafter  referred  to  as  "Royal   Phoenix").
Collectively,  DHPI  and Royal Phoenix are hereinafter referred  to  as  "the
Parties".

                                 WITNESSETH

WHEREAS,  DHPI  a Publicly Traded Company that private labels various  beauty
and  health  care products, including substantial formulations  of  vitamins,
which DHPI has developed over a period of several years, and

WHEREAS,  Royal  Phoenix  desires  an  agreement  for  the  manufacture   and
distribution  for a line of vitamins currently produced by DHPI as  described
in Exhibit A, and DHPI is willing to enter into such an agreement.

WHEREAS,  Royal Phoenix was a spin off company from DHPI for the  purpose  of
marketing  independent of DHPI a line of vitamins primarily in  the  domestic
market.  products and related products primarily through direct market  media
such as the Internet, and

WHEREAS,  Royal  Phoenix  desires to obtain  an  agreement  for  purposes  of
licensing, distributing, selling, and marketing, and using the Royal  Phoenix
Vitamin Group described in Exhibit A, (the "Royal Phoenix Vitamin Group"), on
an exclusive basis.

THEREFORE,  in  consideration of the mutual covenants  contained  herein  and
other good and valuable consideration, it is agreed as follows.






                       DEFINITIONS AND INTERPRETATIONS

Captions and Section Numbers.
The headings and section references in this Agreement are for convenience  of
reference only and do not form a part of this Agreement and are not  intended
to  interpret, define or limit the scope, extent or intent of this  Agreement
or any provisions thereof.

Extended Meanings.
The  words  "hereof", "herein", "hereunder", "hereto" and similar expressions
used  in  any clause. Paragraph or section of this Agreement and any Addendum
and/or  Exhibit attached to this Agreement shall relate to the whole of  this
Agreement  including any attached Addendum and/or Exhibit  and  not  to  that
clause, paragraph or section only, unless otherwise expressly provided.

Number and Gender.
In  this  Agreement words importing the masculine gender include the feminine
or  neuter  gender  and words in the singular include the  plural,  and  vice
versa.

Section References and Schedules.
Any  reference  to  a particular "article", "section", "paragraph"  or  other
subdivision  of this Agreement and any reference to a schedule,  addendum  or
exhibit  by  name, number and/or letter shall mean the appropriate  schedule,
addendum  or  exhibit  attached to this Agreement and by  such  reference  is
incorporated into and made part of this Agreement.

"Royal  Phoenix  Vitamin  Group" shall mean all confidential  or  proprietary
information, trade secrets and know how relating to the Royal Phoenix Vitamin
Group as such technology is further described on Exhibit A to this Agreement.
The  Royal  Phoenix  Vitamin Group is sometimes referred  to  herein  as  the
"Licensed Technology").

"Licensed  Rights"  means  all rights under any, copyright,  confidential  or
proprietary  information, trade secrets and know-how relating  to  the  Royal
Phoenix Vitamin Group, and includes the Licensed Technology.

"Licensed  Tool(s)"  shall include coding systems, proprietary  manufacturing
systems,  development  methodologies, and  documentation  that  encompass  or
incorporate  or are based on any of the Royal Phoenix Vitamin Group,  but  do
not  include products, and services that result from "Authorized Use" of  the
Licensed Tools.  Licensed Tools specifically excludes Royal Phoenix marketing
implementations of the Royal Phoenix Vitamin Group.

"Authorized  Use" refers to those activities and Licensed Rights  granted  by
Licensee  under  this Agreement to everyone who purchases or  sub-licenses  a
Licensed Tool.

"Net Sales" means the gross amounts received by Licensee worldwide, from  the



sales,  license or disposal of Licensed Tools, less commissions,  credit  for
returns,  customary  trade discounts, deductions for transportation  charges,
and  taxes  and  duties directly imposed on the sale.  Except  for  customary
trade  discounts, should Licensee sell, rent or dispose of any Licensed  Tool
in  a non arm's-length transaction, the Net Sales shall be computed based  on
proceeds from sales of a similar product in an arms-length transaction.

"Reasonable  Effort"  means  a reasonable program  of  supporting  technology
improvements  and marketing that expands industry adoptions, installed  base,
and commercial use of the Royal Phoenix Vitamin Group.

"Improvement(s)"  shall  mean  inventions,  modifications,   adaptations   or
improvements,  which  relate to or are based on  the  Royal  Phoenix  Vitamin
Group.

"Sublicensee" shall mean a person or entity to whom Licensee has granted  the
right   under   the   Licensed  Technology  to  develop,  manufacture,   have
manufactured, use, market and/or sell the Licensed Tools.

"Sublicense Income" shall mean the gross amount (net of tax withholdings  for
taxes  which  Licensee  is  obligated  to  pay)  received  by  Licensee  from
Sublicensees  for or on account of sublicenses of any of the  rights  granted
Licensee  hereunder  and  the  sale of Licensed Tools,  including  royalties,
license fees, milestone payments, option fees and other amounts paid or other
non-monetary   financial  benefit  provided  to  Licensee  by   Sublicensees.
Sublicensee  Income  shall not include amounts received by  Licensee  from  a
Sublicensee for an equity investment in Licensee.


AGREEMENT

1.   GRANT OF LICENSE

1.1. Exclusive License.  DHPI hereby grants to Royal Phoenix, subject to the
conditions set forth in this Agreement, an exclusive non transferable license
under the Licensed Rights to make, have made, use, market, import, have
imported, lease, sell, distribute, offer for sale, or otherwise dispose of
Royal Phoenix Vitamin Group, as herein defined, utilizing Licensed Tools
throughout the world, including the right to make copies of, make derivative
works based on, and distribute any copyrighted works within the Royal Phoenix
Vitamin Group. The license is strictly limited to Royal Phoenix's right to
make, use, market, import, lease, sell, distribute, offer for sale, or
otherwise dispose of Royal Phoenix Vitamin Group, and such license may not be
utilized for any other purpose without permission of DHPI. Royal Phoenix
Vitamin Group is a proprietary product developed by DHPI utilizing Licensed
Tools. Royal Phoenix Vitamin Group is a  line of specially formulated
vitamins.

1.2. Sublicense.  Licensee shall have the right to grant sublicenses to third



          parties, subject to the terms of this Agreement.


     1.3. Reservation of Rights.  DHPI expressly reserves all rights not granted
          to Royal Phoenix in this Agreement for his own  purposes.

5. Manufacture, Distribution, and Shipment. The Parties herein mutually agree
that  DHPI  shall be responsible for the manufacture, shipment, distribution,
labeling,  and  collection of payments, generally referred to herein  as  the
"Manufacture and Distribution Process").

6.  Term.  This Agreement shall begin ninety (90) days from the date DHPI  is
prepared  to  make  the  first shipment of Product and shall  continue  until
December 31, 2010.

7.  Price.   Since  the Parties are not now certain of the  actual  costs  of
manufacturing, bottling, boxing, and charge card authorizations and shipping,
the  price  of  the  Product shall be DHPI's cost of production  including  a
reasonable alowance for overhead plus 30% of such cost and overhead. The cost
of  production and the allowance for overhead shall be mutually determined by
the Parties, and if no agreement can be reached, an indendent accounting firm
selected  by  the  Parties, using as a basis for overhead  DHPI's  books  and
records for the prior two quarters.
      Periodic  Price Revisions. DHPI may, effective at the end of  each  six
month  period, increase the price of the Product by giving Royal  Phoenix  at
least  15  days'  prior written notice. Increase prices shall  apply  to  any
products shipped after the expiration of such quarter unless DHPI shall  have
received from Royal Phoenix, prior to the expiration of such quarter, written
notice  that  Royal  Phoenix is unwilling to accept such increase,  in  which
event   Royal  Phoenix  may  terminate  this  agreement.  In  the  event   of
termination, then in that event, Royal Phoenix shall be entitled to  continue
to  utilize the Royal Phoenix Vitamin Group as defined herein, however,  DHPI
will  have  no further responsibility to take orders, manufacture  the  Royal
Phoenix Vitamin Group, bottle the product, or ship the product.

8.  Exclusive  Dealings.   DHPI  represents that  during  the  term  of  this
Agreement  that  DHPI will not sell, give away or otherwise transfer  to  any
other  person during the term of this Agreement any of the Product,  for  the
uses  permitted  under this Agreement, without the prior written  consent  of
Royal Phoenix.

9. Delivery.  DHPI shall deliver all goods to a carrier for transportation to
customers  of Royal Phoenix's, as designated by Royal Phoenix, but all  costs
of transportation shall be borne by Royal Phoenix and all risks of loss shall
pass  to  Royal  Phoenix when the goods are delivered  to  the  carrier.  The
Parties  agree that DHPI is handling the entire Manufacture and  Distribution
Process and the price paid to DHPI will include coverage of payments for  the
entire Manufacture and Distribution Process.

10. Acceptance.  Upon each delivery of Product, Royal Phoenix customers shall



inspect  the  delivered  Product to determine  whether  such  Product  is  in
conformity  with  the specifications set out in Exhibit  A  hereto.  If  such
delivery  of  Product  is not in conformity thereto, Royal  Phoenix   or  the
customer shall notify DHPI of such non-conformity within seven days  of  such
delivery.   If  Royal Phoenix  or its customers have not notified  DHPI  that
such delivery of Product is not in conformity within such time, Royal Phoenix
or  its customers shall be deemed to have accepted the Product delivered.  If
Royal  Phoenix so notifies DHPI that the delivered Product is non-conforming,
DHPI  shall replace the rejected Product within twenty days from the date  of
rejection.

11.  Billing  and  Payment. Products being ordered shall include  payment  by
charge  card  only from customers directly to DHPI, or check or  charge  card
from  Royal  Phoenix.   A separate account shall be maintained  by  DHPI  for
receipt of payments on orders. At the end of each quarter, a accounting shall
be prepared showing the volume of product, the percentage of costs to be paid
to DHPI and the balance of costs paid to Royal Phoenix.

12. Trade Secrets and Inventions.
Royal Phoenix shall treat as proprietary any and all information belonging to
DHPI, it's affiliates or any third parties disclosed to Royal Phoenix in  the
course of the relationship between DHPI and Royal Phoenix.

13. Termination of Agreement.
This  Agreement may not be terminated by either party prior to the expiration
of the term provided in paragraph 6 above, except as follows.
     a.   Upon the bankruptcy or liquidation of the other party, whether
          voluntary or involuntary,
     b.   Upon the other party taking the benefit of any insolvency law,
     c.   Upon the other party having or applying for a receiver appointed for
          either party,
     d.   For cause, and/or
     e.   As provided for in paragraph 14, immediately below.

14. Early Termination.
In  the event Royal Phoenix fails or refuses to cooperate with DHPI, fails or
refuses  to  make  timely  payment  of the compensation  set  forth  in  this
Agreement,  DHPI  shall have the right to terminate any  further  performance
under  this  Agreement.  In  such event, and upon notification  thereof,  all
invoicing shall become immediately due and payable and/or deliverable.

15. Notices.
All  notices hereunder shall be in writing and addressed to the party at  the
address  herein set forth, or at such other address which notice pursuant  to
this  section  may  be  given, and shall be given by either  certified  mail,
express  mail  or  other overnight courier service. Notices shall  be  deemed
given  upon  the earlier of actual receipt or three (3) business  days  after



being  mailed or delivered to such courier service. Any notices to  be  given
hereunder shall be effective if executed by and/or sent by the attorneys  for
the  Parties giving such notice and, in connection therewith, the Parties and
their  respective counsel agree that in giving such notice such  counsel  may
communicate  directly in writing with such party to the extent  necessary  to
give such notice.

16. Attorney Fees
In  the  event either party is in default of the terms or conditions of  this
Agreement  and legal action is initiated or suit be entered as  a  result  of
such  default,  the prevailing party shall be entitled to recover  all  costs
incurred  as  a  result of such default including reasonable  attorney  fees,
expenses and court costs through trial, appeal and to final disposition.

17. Return of Records.
Upon  termination of this Agreement, Royal Phoenix shall deliver all records,
notes,  data, memorandum, models and equipment of any nature that are in  the
control  of Royal Phoenix that are the property of or relate to the  business
of  DHPI, except that Royal Phoenix shall retain one copy of printed material
for retention in the Royal Phoenix library.

18. Ownership of Materials.
All right, title and interest in and to the Royal Phoenix Vitamin Group to be
produced  by DHPI in connection with this Agreement shall be and  remain  the
sole  and exclusive property of Royal Phoenix. Thus, upon termination,  Royal
Phoenix has the right to continue the production of the product with a  third
party manufacturer.

19. Agreement Not To Hire.
Royal  Phoenix  understands and appreciates that DHPI  invests  a  tremendous
amount of time, energy, resources and expertise in the training and education
of  its  employees and subcontractors to be able to provide the very  Product
Royal  Phoenix requires. Further, Royal Phoenix understands that in the event
an  employee or subcontractor of DHPI is enticed to leave, then DHPI shall be
damaged  in  an  amount  the Parties are not capable of  calculating  at  the
present  time.  Therefore, Royal Phoenix agrees not to  offer  employment  or
subcontractor status to any employee or subcontractor of DHPI, nor  to  allow
any  employee, officer, director, shareholder or consultant of Royal  Phoenix
to  offer such employment or subcontractor status with Royal Phoenix  or  any
other  company, concern, venture or entity with whom officers,  directors  or
consultants  of  Royal Phoenix are employed, associated or hold  a  financial
stake  in,  for  a period of three (3) years from the date of  expiration  or
termination hereof.

20. Exclusion With Respect To Partnership.
The  Parties agree that in no way shall this Agreement be construed as  being
an  act  of  partnership between the Parties hereto and that no party  hereto
shall have, as a result of the execution of this Agreement, any liability for
the commitments of any other party of any type, kind, son or variety.

21. Time Is Of The Essence.
Time  is  hereby expressly made of the essence of this Agreement with respect



to the performance by the Parties of their respective obligations hereunder.

22. Inurement.
This  Agreement shall inure to the benefit of and be binding upon the Parties
hereto  and  their  respective  heirs,  executors,  administrators,  personal
representatives, successors, assigns and any addendum attached hereto.

23. Entire Agreement.
This  Agreement contains the entire agreement of the Parties. It is  declared
by  the  Parties  that  there  are no other oral  or  written  agreements  or
understanding  between  them  affecting this Agreement  or  relating  to  the
business  of DHPI. This Agreement supersedes all previous agreements  between
DHPI and Royal Phoenix.

24. Amendments
     This Agreement may be modified or amended provided such modifications or
amendments  are  mutually agreed upon by and between the Parties  hereto  and
that  said  modifications or amendments are made only  by  an  instrument  in
writing  signed  by the Parties or an oral agreement to the extent  that  the
Parties carry it out.

25. Waivers.
No  waiver  of  any provision or condition of this Agreement shall  be  valid
unless  executed in writing and signed by the party to be bound thereby,  and
then  only to the extent specified in such waiver. No waiver of any provision
or  condition of this Agreement shall be construed as a waiver of  any  other
provision  or  condition  of this Agreement, and no  present  waiver  of  any
provision  or  condition of this Agreement shall be  construed  as  a  future
waiver of such provision or condition.

26. Non-waiver.
The failure of either party, at any time, to require any such performance  by
any other party shall not be constructed as a waiver of such right to require
such  performance, and shall in no way affect such party's right  to  require
such  performance and shall in no way affect such party's right  subsequently
to require a full performance hereunder.

27. Construction of Agreement.
Each party and its counsel have participated fully in the review and revision
of  this  Agreement. Any rule of construction to the effect that  ambiguities
are  to  be  resolved  against the drafting party  shall  not  apply  in  the
interpretation of this Agreement.

28. Applicable Law.
THIS  AGREEMENT IS EXECUTED PURSUANT TO AND SHALL BE INTERPRETED AND GOVERNED
FOR  ALL PURPOSES BY THE LAWS OF THE STATE OF NEVADA FOR WHICH THE COURTS  IN
CLARK  COUNTY,  NEVADA SHALL HAVE JURISDICTION WITHOUT GIVING EFFECT  TO  THE
CHOICE OR LAWS OR CONFLICT OF LAWS RULES THEREOF OR OF ANY STATE.



29. Severability.
If any provision of this Agreement shall be held to be contrary to law, void,
invalid  or  unenforceable  for any reason, such provision  shall  be  deemed
severed  from this Consulting Agreement and the remaining provisions of  this
Agreement  shall continue to be valid and enforceable. If a Court finds  that
any  provision  of  this  Agreement is contrary  to  law,  void,  invalid  or
unenforceable and that by limiting such provision it would become  valid  and
enforceable, then such provision shall be deemed to be written, construed and
enforced as so limited.

30. Acceptance by DHPI.
This Agreement is not valid or binding upon DHPI unless and until executed by
its   Chief  Executive  Officer,  Chief  Operating  Officer  duly  authorized
executive officer of DHPI at its home office in Scottsdale, Arizona.

31. Execution In Counterpart: Telecopy-Fax.
This Agreement may be executed in counterparts, not withstanding the date  or
dates  upon which this Consulting Agreement is executed and delivered by  any
of  the Parties, and shall be deemed to be an original and all of which shall
constitute  one  and  the ISNe Agreement effective as of the  reference  date
first  written  below.  The fully executed telecopy  (fax)  version  of  this
Agreement shall be construed by all parties hereto as an original version  of
said Agreement.

     IN  WITNESS WHEREOF, the Parties hereto have set forth their  hands  and
seal  in  execution of this Agreement made this 18th day of October 2000,  by
and between;

     For and in behalf of Royal Phoenix:          For and in behalf of DHPI:

     By:/s/JOSEPH SCOTT WILSON               By:/s/JOHNNY SHANNON
       Joseph Scott Wilson, President           Johnny Shannon, President

Witnessed by:
Notary Public



                                  EXHIBIT A

                 Description of Royal Phoenix Vitamin Group